242 related articles for article (PubMed ID: 32299612)
1. Preparation of engineered extracellular vesicles with full-length functional PD-1 membrane proteins by baculovirus expression system.
Ishikawa R; Yoshida S; Sawada SI; Sasaki Y; Akiyoshi K
Biochem Biophys Res Commun; 2020 Jun; 526(4):967-972. PubMed ID: 32299612
[TBL] [Abstract][Full Text] [Related]
2. Cancer-associated Fibroblast-derived Extracellular Vesicles Mediate Immune Escape of Bladder Cancer via PD-L1/PD-1 Expression.
Feng R; Li Z; Ge G; Wang C; Jia Y; Ouyang J
Endocr Metab Immune Disord Drug Targets; 2023; 23(11):1410-1420. PubMed ID: 36852791
[TBL] [Abstract][Full Text] [Related]
3. Immune evasion mediated by PD-L1 on glioblastoma-derived extracellular vesicles.
Ricklefs FL; Alayo Q; Krenzlin H; Mahmoud AB; Speranza MC; Nakashima H; Hayes JL; Lee K; Balaj L; Passaro C; Rooj AK; Krasemann S; Carter BS; Chen CC; Steed T; Treiber J; Rodig S; Yang K; Nakano I; Lee H; Weissleder R; Breakefield XO; Godlewski J; Westphal M; Lamszus K; Freeman GJ; Bronisz A; Lawler SE; Chiocca EA
Sci Adv; 2018 Mar; 4(3):eaar2766. PubMed ID: 29532035
[TBL] [Abstract][Full Text] [Related]
4. Fusogenic Hybrid Extracellular Vesicles with PD-1 Membrane Proteins for the Cytosolic Delivery of Cargos.
Ishikawa R; Yoshida S; Sawada SI; Sasaki Y; Akiyoshi K
Cancers (Basel); 2022 May; 14(11):. PubMed ID: 35681615
[TBL] [Abstract][Full Text] [Related]
5. Extracellular vesicle-based drug delivery in cancer immunotherapy.
Najafi S; Majidpoor J; Mortezaee K
Drug Deliv Transl Res; 2023 Nov; 13(11):2790-2806. PubMed ID: 37261603
[TBL] [Abstract][Full Text] [Related]
6. Extracellular vesicle-mediated immunoregulation in cancer.
Yamamoto T; Yamamoto Y; Ochiya T
Int J Hematol; 2023 May; 117(5):640-646. PubMed ID: 35951282
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial Lon-induced mtDNA leakage contributes to PD-L1-mediated immunoescape via STING-IFN signaling and extracellular vesicles.
Cheng AN; Cheng LC; Kuo CL; Lo YK; Chou HY; Chen CH; Wang YH; Chuang TH; Cheng SJ; Lee AY
J Immunother Cancer; 2020 Dec; 8(2):. PubMed ID: 33268351
[TBL] [Abstract][Full Text] [Related]
8. Rapid Capturing and Chemiluminescent Sensing of Programmed Death Ligand-1 Expressing Extracellular Vesicles.
Khan A; Di K; Khan H; He N; Li Z
Biosensors (Basel); 2022 Apr; 12(5):. PubMed ID: 35624582
[TBL] [Abstract][Full Text] [Related]
9. Surface molecules of extracellular vesicles secreted by the helminth pathogen Fasciola hepatica direct their internalisation by host cells.
de la Torre-Escudero E; Gerlach JQ; Bennett APS; Cwiklinski K; Jewhurst HL; Huson KM; Joshi L; Kilcoyne M; O'Neill S; Dalton JP; Robinson MW
PLoS Negl Trop Dis; 2019 Jan; 13(1):e0007087. PubMed ID: 30657764
[TBL] [Abstract][Full Text] [Related]
10. PD-L1-Expressing Extracellular Vesicles for the Treatment of Pneumonia.
Wu Y; Wang H; Song A; Wang X; Ma Q; Yao C; Xu J; Dai H; Wang C; Lu T; Xu F
ACS Biomater Sci Eng; 2023 Nov; 9(11):6464-6471. PubMed ID: 37844209
[TBL] [Abstract][Full Text] [Related]
11. Role of Extracellular Vesicle Surface Proteins in the Pharmacokinetics of Extracellular Vesicles.
Charoenviriyakul C; Takahashi Y; Morishita M; Nishikawa M; Takakura Y
Mol Pharm; 2018 Mar; 15(3):1073-1080. PubMed ID: 29382201
[TBL] [Abstract][Full Text] [Related]
12. Overcoming the resistance of hepatocellular carcinoma to PD-1/PD-L1 inhibitor and the resultant immunosuppression by CD38 siRNA-loaded extracellular vesicles.
Deng J; Ke H
Oncoimmunology; 2023; 12(1):2152635. PubMed ID: 36605619
[TBL] [Abstract][Full Text] [Related]
13. Development and single-particle analysis of hybrid extracellular vesicles fused with liposomes using viral fusogenic proteins.
Ishikawa R; Yoshida S; Sawada SI; Sasaki Y; Akiyoshi K
FEBS Open Bio; 2022 Jun; 12(6):1178-1187. PubMed ID: 35384397
[TBL] [Abstract][Full Text] [Related]
14. Quantitative proteomic analysis of extracellular vesicles in response to baculovirus infection of a Trichoplusia ni cell line.
Hausjell CS; Ernst W; Grünwald-Gruber C; Arcalis E; Grabherr R
PLoS One; 2023; 18(1):e0281060. PubMed ID: 36716331
[TBL] [Abstract][Full Text] [Related]
15. The role of extracellular vesicles and PD-L1 in glioblastoma-mediated immunosuppressive monocyte induction.
Himes BT; Peterson TE; de Mooij T; Garcia LMC; Jung MY; Uhm S; Yan D; Tyson J; Jin-Lee HJ; Parney D; Abukhadra Y; Gustafson MP; Dietz AB; Johnson AJ; Dong H; Maus RL; Markovic S; Lucien F; Parney IF
Neuro Oncol; 2020 Jul; 22(7):967-978. PubMed ID: 32080744
[TBL] [Abstract][Full Text] [Related]
16. Extracellular Vesicles From Gastric Cancer Cells Induce PD-L1 Expression on Neutrophils to Suppress T-Cell Immunity.
Shi Y; Zhang J; Mao Z; Jiang H; Liu W; Shi H; Ji R; Xu W; Qian H; Zhang X
Front Oncol; 2020; 10():629. PubMed ID: 32477934
[TBL] [Abstract][Full Text] [Related]
17. Appearance of claudin-5
Paul D; Baena V; Ge S; Jiang X; Jellison ER; Kiprono T; Agalliu D; Pachter JS
J Neuroinflammation; 2016 Nov; 13(1):292. PubMed ID: 27852330
[TBL] [Abstract][Full Text] [Related]
18. In Situ Simultaneous Detection of Surface Protein and microRNA in Clustered Extracellular Vesicles from Cancer Cell Lines Using Flow Cytometry.
Lee JY; Lee S; Lee H; Tran TTP; Kim BC; Rhee WJ
ACS Biomater Sci Eng; 2023 Nov; 9(11):6369-6378. PubMed ID: 37905510
[TBL] [Abstract][Full Text] [Related]
19. Glycolipid-Anchored Proteins on Bioengineered Extracellular Vesicles for Lipopolysaccharide Neutralization.
Uppu DS; Min Y; Kim I; Kumar S; Park J; Cho YK
ACS Appl Mater Interfaces; 2021 Jun; 13(25):29313-29324. PubMed ID: 34137258
[TBL] [Abstract][Full Text] [Related]
20. Targeting extracellular vesicles to injured tissue using membrane cloaking and surface display.
Antes TJ; Middleton RC; Luther KM; Ijichi T; Peck KA; Liu WJ; Valle J; Echavez AK; Marbán E
J Nanobiotechnology; 2018 Aug; 16(1):61. PubMed ID: 30165851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
